CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Safety evaluation of emicizumab prophylaxis in individuals with haemophilia A
Author
Adamkewicz J
Adverse Events FDA
+18 more
ATHN 7: Hemophilia Natural History Study - Full Text View - ClinicalTrials.gov
Castaman G
De Ford C
Emicizumab Info
Franchini M
Franchini M
Franchini M
Gringeri A
Hemlibra Highlights of Prescribing Information
Lee L
MedWatch: The FDA Safety Information and Adverse Event Reporting Program | FDA
Négrier C
Recommendation on the Use and Management of Emicizumab-kxwh (Hemlibra®) for Hemophilia A with and without Inhibitors
Roche H-L
Roche H-L
Roche H-L
Wall C
Young G
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref